Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

INTRODUCTION: Theoretical risks of biologic agents remain under study. OBJECTIVE: The aim of this study was to integrate 1-year safety data from 12 ustekinumab registrational trials. METHODS: Patients had moderate-to-severe plaque psoriasis, active psoriatic arthritis (PsA) (± methotrexate), or mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Subrata, Gensler, Lianne S., Yang, Zijiang, Gasink, Chris, Chakravarty, Soumya D., Farahi, Kamyar, Ramachandran, Paraneedharan, Ott, Elyssa, Strober, Bruce E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520311/
https://www.ncbi.nlm.nih.gov/pubmed/30739254
http://dx.doi.org/10.1007/s40264-019-00797-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520311/
https://www.ncbi.nlm.nih.gov/pubmed/30739254
http://dx.doi.org/10.1007/s40264-019-00797-3

Ejemplares similares